Merz's Novabel Suspended In EU, Pausing New Business Strategy
This article was originally published in The Gray Sheet
Executive Summary
U.K authorities told health care professionals and aesthetic practitioners on August 12 not to use Merz Pharmaceuticals' dermal filler Novabel (alginate) because of a potential association with skin nodules and induration, particularly in the infra-orbital area, and to return all unused product to the company